Work from us and others has shown that old age, comorbidities such as diabetes and hypertension, behavioral factors like smoking, and molecular factors like androgen receptor signaling and TMPRSS2 may contribute to the increased risk of COVID-19 for prostate cancer patients [3]. Here, TMPRSS2 is linked to Hypertension.